DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20214531

Depression and coping strategies used among adolescents with cystic fibrosis

Surya Kant Tiwari, Rimple Sharma, Poonam Joshi, Sushil Kumar Kabra

Abstract


Background: Cystic fibrosis (CF), an autosomal recessive monogenic chronic disorder affects the lungs, pancreas, and other exocrine glands, and manifests as recurrent respiratory infections, malabsorption, and a myriad of complications pertaining to other systems like hepatobiliary, endocrine and reproductive systems.  Objectives were to assess the level of depression among adolescents with CF, to assess the coping strategies used by adolescents with CF and to find an association between selected sociodemographic and clinical variables with depression.

Methods: In a cross-sectional survey, 30 adolescents with CF in the age group of 12-18 years, attending the specialty clinic of a selected tertiary care facility were enrolled using a purposive sampling technique. Tools consisting of sociodemographic and clinical profile, patient health questionnaire (PHQ)-9, and ways of coping with CF were used for data collection.

Results: Most of the adolescents with CF (66.7%) had depression of varying severity with 36.7% having moderate-severe to severe depression. The frequently used coping strategies by the adolescents with CF were hopefulness (76.66±11.29), followed by optimistic acceptance (70.23±13.04).  The individual coping strategy with the highest mean score was “having confidence on doctor and treatment” (3.83±0.37), while ‘I cry, eat, drink or take drugs’ had the lowest score (1.6±1.00).

Conclusion: Depression is a common problem among adolescents with CF requiring regular screening and referral to experts for enhancing their coping strategy of optimistic acceptance. 


Keywords


CF, Adolescents, Depression, Coping strategies

Full Text:

PDF

References


Backström-Eriksson L, Sorjonen K, Bergsten-Brucefors A, Hjelte L, Melin B. Anxiety and depression in adults with cystic fibrosis: a comparison between patients and the general population in Sweden and three other European countries. BMC Pulm Med. 2015;15.

Van der Doef HPJ, Kokke FTM, Van der Ent CK, Houwen RHJ. Intestinal Obstruction Syndromes in Cystic Fibrosis: Meconium Ileus, Distal Intestinal Obstruction Syndrome, and Constipation. Curr Gastroenterol Rep. 2011;13(3):265-70.

Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370(9590):851-8.

Catastini P, Di Marco S, Furriolo M, Genovese C, Grande A, Iacinti E, et al. The prevalence of anxiety and depression in Italian patients with cystic fibrosis and their caregivers. Pediatr Pulmonol. 2016;51(12):1311-9.

Smith BA, Cogswell A, Garcia G. Vitamin D and Depressive Symptoms in Children with Cystic Fibrosis. Psychosomatics. 2014;55(1):76-81.

Ploessl C, Pettit RS, Donaldson J. Prevalence of Depression and Antidepressant Therapy Use in a Pediatric Cystic Fibrosis Population. Ann Pharmacother. 2014;48(4):488-93.

Quittner AL, Goldbeck L, Abbott J, Duff A, Lambrecht P, Solé A et al. Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries. Thorax. 2014;69(12):1090-7.

Modi AC, Driscoll KA, Montag-Leifling K, Acton JD. Screening for symptoms of depression and anxiety in adolescents and young adults with cystic fibrosis. Pediatr Pulmonol. 2011;46(2):153-9.

Duff AJA, Abbott J, Cowperthwaite C, Sumner C, Hurley MA, Quittner A. Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: A cross-sectional study. J Cyst Fibros. 2014;13(6):745-53.

Smith BA, Modi AC, Quittner AL, Wood BL. Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatr Pulmonol. 2010;45(8):756-63.

Kioumis IP, Zarogoulidis K, Huang H, Li Q, Dryllis G, Pitsiou G, et al. Pneumothorax in cystic fibrosis. J Thorac Dis. 2014;6(4):S480-7.

Kayani K, Mohammed R, Mohiaddin H. Cystic Fibrosis-Related Diabetes. Front Endocrinol [Internet]. 2018;9.

Mc Hugh R, Mc Feeters D, Boyda D, O’Neill S. Coping styles in adults with cystic fibrosis: implications for emotional and social quality of life. Psychol Health Med. 2016;21(1):102-12.

Sviridova TV, Namazova-Baranova LS, Lazurenko SB, Simonova OlgaI. Psychological Aspects in Treatment of Children with Cystic Fibrosis. Procedia-Soc Behav Sci. 2014;146:461-5.

Abbott J. Coping with cystic fibrosis. J R Soc Med. 2003;96(43):42-50.

Quittner AL, Barker DH, Snell C, Grimley ME, Marciel K, Cruz I. Prevalence and impact of depression in cystic fibrosis: Curr Opin Pulm Med. 2008;14(6):582-8.

Cronly J, Duff AJ, Riekert KA, Perry IJ, Fitzgerald AP, Horgan A et al. Online versus paper-based screening for depression and anxiety in adults with cystic fibrosis in Ireland: a cross-sectional exploratory study. BMJ Open. 2018 21;8(1):e019305.

Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737-44.

Abbott J, Dodd M, Gee L, Webb K. Ways of coping with cystic fibrosis: implications for treatment adherence. Disabil Rehabil. 2001;23(8):315-24.

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety, Thorax. Available at: https://thorax.bmj.com/content/71/1/26. Accessed on 2019 Oct 9.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-13.

Goldbeck L, Besier T, Hinz A, Singer S, Quittner AL, TIDES Group. Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis. Chest. 2010;138(4):929-36.

Knudsen KB, Pressler T, Mortensen LH, Jarden M, Skov M, Quittner AL et al. Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis. Springer Plus. 2016;5(1):1216.

Askew K, Bamford J, Hudson N, Moratelli J, Miller R, Anderson A et al. Current characteristics, challenges and coping strategies of young people with cystic fibrosis as they transition to adulthood. Clin Med Lond Engl. 2017;17(2):121-5.